Vanguard Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$412M Buy
3,945,020
+68,078
+2% +$7.11M 0.01% 1129
2025
Q1
$452M Sell
3,876,942
-25,537
-0.7% -$2.98M 0.01% 1048
2024
Q4
$330M Sell
3,902,479
-92,866
-2% -$7.86M 0.01% 1284
2024
Q3
$359M Buy
3,995,345
+253,343
+7% +$22.8M 0.01% 1222
2024
Q2
$301M Buy
3,742,002
+1,724
+0% +$139K 0.01% 1258
2024
Q1
$298M Buy
3,740,278
+43,512
+1% +$3.47M 0.01% 1281
2023
Q4
$294M Sell
3,696,766
-32,360
-0.9% -$2.58M 0.01% 1299
2023
Q3
$261M Sell
3,729,126
-13,627
-0.4% -$952K 0.01% 1295
2023
Q2
$269M Buy
3,742,753
+257,003
+7% +$18.5M 0.01% 1307
2023
Q1
$215M Buy
3,485,750
+68,122
+2% +$4.2M 0.01% 1413
2022
Q4
$264M Buy
3,417,628
+306,128
+10% +$23.6M 0.01% 1266
2022
Q3
$139M Buy
3,111,500
+309,362
+11% +$13.8M ﹤0.01% 1604
2022
Q2
$107M Buy
2,802,138
+102,648
+4% +$3.93M ﹤0.01% 1778
2022
Q1
$112M Buy
2,699,490
+13,868
+0.5% +$574K ﹤0.01% 1877
2021
Q4
$101M Buy
2,685,622
+28,737
+1% +$1.09M ﹤0.01% 1975
2021
Q3
$87.6M Buy
2,656,885
+42,740
+2% +$1.41M ﹤0.01% 2055
2021
Q2
$176M Buy
2,614,145
+10,405
+0.4% +$702K ﹤0.01% 1695
2021
Q1
$147M Sell
2,603,740
-37,334
-1% -$2.11M ﹤0.01% 1740
2020
Q4
$215M Buy
2,641,074
+52,163
+2% +$4.25M 0.01% 1429
2020
Q3
$184M Buy
2,588,911
+655,351
+34% +$46.7M 0.01% 1333
2020
Q2
$159M Buy
1,933,560
+539,754
+39% +$44.4M 0.01% 1420
2020
Q1
$82M Buy
1,393,806
+31,862
+2% +$1.87M ﹤0.01% 1638
2019
Q4
$141M Buy
1,361,944
+102,689
+8% +$10.6M ﹤0.01% 1580
2019
Q3
$25.5M Buy
1,259,255
+106,970
+9% +$2.17M ﹤0.01% 2365
2019
Q2
$29.7M Buy
1,152,285
+250,498
+28% +$6.45M ﹤0.01% 2343
2019
Q1
$12.8M Buy
901,787
+563,083
+166% +$8.01M ﹤0.01% 2691
2018
Q4
$955K Sell
338,704
-233,997
-41% -$660K ﹤0.01% 3575
2018
Q3
$1.98M Sell
572,701
-7,904
-1% -$27.3K ﹤0.01% 3534
2018
Q2
$1.86M Buy
580,605
+46,926
+9% +$150K ﹤0.01% 3520
2018
Q1
$1.31M Buy
533,679
+43,927
+9% +$108K ﹤0.01% 3585
2017
Q4
$2.74M Buy
489,752
+69,830
+17% +$391K ﹤0.01% 3329
2017
Q3
$2.33M Buy
419,922
+143,307
+52% +$796K ﹤0.01% 3356
2017
Q2
$1.52M Sell
276,615
-58,130
-17% -$320K ﹤0.01% 3462
2017
Q1
$1.31M Buy
334,745
+62,556
+23% +$244K ﹤0.01% 3513
2016
Q4
$1.84M Buy
272,189
+18,440
+7% +$124K ﹤0.01% 3383
2016
Q3
$2M Buy
253,749
+5,812
+2% +$45.8K ﹤0.01% 3395
2016
Q2
$1.87M Buy
247,937
+39,513
+19% +$298K ﹤0.01% 3404
2016
Q1
$1.79M Buy
+208,424
New +$1.79M ﹤0.01% 3423